Pillstats
Rx only · Injection, Solution · Intravenous

Fluorouracil

Brands: Favlyxa · Fluorouracil

11 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US28 NDCs
11 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)4492
US makers11 labelers
Packages42
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

12K23K35K46K2025 Q12025 Q22025 Q32025 Q42026 Q1
29K
Rx · 2026 Q1
2.4M
Units dispensed
-27%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it11 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Fresenius Kabi USA, LLCunknown9SUPPLYING
BluePoint Laboratoriesunknown6SUPPLYING
Xiromed, LLC.unknown4SUPPLYING
Alembic Pharmaceuticals Limitedunknown4SUPPLYING
Eugia US LLCunknown4SUPPLYING
Accord Healthcare Inc.unknown4SUPPLYING
Gland Pharma Limitedunknown4SUPPLYING
Meitheal Pharmaceuticals Inc.unknown2SUPPLYING
Avyxa Pharma, LLCunknown2SUPPLYING
Sagent Pharmaceuticalsunknown2SUPPLYING
ProPharma Distributionunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jun 28, 2019
    RECALLRecall (Class I): Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL), 100 mL fill in a 100 mL vial, Rx Only, Mfd. by: Fresenius Kabi…

    Presence of Particulate Matter; glass particulates — Recalling firm: Fresenius Kabi USA, LLC — Nationwide USA and Puerto Rico